Search Results

You are looking at 1 - 10 of 22 items for :

  • "Middle East and North Africa" x
  • Refine by Access: All x
Clear All
Full access

Omar Shamieh and Abdul-Rahman Jazieh

A n initiative was launched to adapt several of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to the Middle East and North Africa (MENA) region. Palliative care was one area of cancer treatment selected because of its high

Full access

Abdul-Rahman Jazieh, Hamdy A. Azim, Joan McClure, and Mohammad Jahanzeb

resources with interested entities. These efforts were translated into regional guidelines in Korea, Japan, and China, and recently the Middle East and North Africa (MENA) region, 5 including countries extending from Morocco to India (West–East) and Turkey

Full access

Abdul Rahman Jazieh

Since its inception in April 2009, the NCCN/Middle East and North Africa (MENA) Guideline Initiative has reached important milestones in the adaptation and implementation of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) in

Full access

Ali Bazarbachi, Hamdy A. Azim, Hussain Alizadeh, Mahmoud Aljurf, Ibrahim Barista, Naeem A. Chaudhri, Zahira Fahed, Omar A. Fahmy, Ardeshir Ghavamzadeh, Mohamed H. Khalaf, Sami Khatib, Aghiad Kutoubi, Semra Paydas, Hanadi Rafii Elayoubi, Ghazi Zaatari, Hamdy M. Zawam, and Andrew D. Zelenetz

Overview I n the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large

Full access

Waleed A. Hassen, Farrok A. Karsan, Farhat Abbas, Yasar Beduk, Ahmed El-Khodary, Marwan Ghosn, Jamal Khader, Raja Khauli, Danny M. Rabah, Ali Shamseddine, and Sandy Srinivas

P rostate cancer is a significant source of morbidity and mortality in the West, and remains the second leading cause of death from a solid malignancy in men in the United States. 1 However, its effect on populations in the Middle East and North

Full access

Abdul-Rahman Jazieh, Hanaa Bamefleh, Ahmet Demirkazik, Rabab Mohamed Gaafar, Fady B. Geara, Mansur Javaid, Jamal Khader, Kian Khodadad, Walid Omar, Ahmed Saadeddin, Hassan Al Sabe, Mohammad Behgam Shadmehr, Amgad El Sherif, Najam Uddin, Mohammad Jahanzeb, and David Ettinger

malignancies. The Egyptian National Cancer Institute data shows that the frequency of lung cancer was not different between 2001 and 2006. 8 Current Status of Lung Cancer Care in the Middle East and North Africa Region The Middle East and North Africa

Full access

Omalkhair Abulkhair, Nagi Saghir, Lobna Sedky, Ahmed Saadedin, Heba Elzahwary, Neelam Siddiqui, Mervat Al Saleh, Fady Geara, Nuha Birido, Nadia Al-Eissa, Sana Al Sukhun, Huda Abdulkareem, Menar Mohamed Ayoub, Fawaz Deirawan, Salah Fayaz, Alaa Kandil, Sami Khatib, Mufid El-Mistiri, Dorria Salem, El Siah Hassan Sayd, Mohammed Jaloudi, Mohammad Jahanzeb, and William I. Gradishar

B reast cancer is the most common malignant disease in women, with an increasing incidence worldwide, especially in developing countries such as the Middle East and North Africa (MENA) region. 1 – 3 However, the mortality rate has declined

Full access

Fikri İçli, Hakan Akbulut, Shouki Bazarbashi, Mehmet Ayhan Kuzu, Mohandas K. Mallath, Kakil Ibrahim Rasul, Scott Strong, Aamir Ali Syed, Faruk Zorlu, and Paul F. Engstrom

Colorectal cancer is less common in the Middle East and South Asia than in western countries, with the rectum the most common primary site, unlike in the United States. A project was planned to address various local issues regarding the management of common cancers, including colorectal cancer, and to adapt the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to the Middle East and North Africa (MENA) region. A survey of oncologists in this geographic area showed that the management practices and issues regarding colorectal cancer are similar to those presented in the NCCN Colorectal Cancer Guidelines. However, 2 major differences exist: most oncologists in the MENA region prefer chest radiograph over CT in pretreatment workup, and almost 50% of them prefer to use cetuximab in the first-line treatment of patients with the wild-type KRAS gene. The committee, comprising 9 oncologists from different countries, proposed 4 modifications to the 2009 version of the NCCN Colorectal Cancer Guidelines for use in the MENA region, relating to 1) short-course preoperative radiotherapy, 2) dose of capecitabine, 3) stereotactic radiotherapy for liver metastasis, and 4) qualification of surgeons performing colorectal surgery. The modification of NCCN Colorectal Cancer Guidelines for use in the MENA region represents a step toward creating a uniform practice in the region based on evidence and local experience.

Full access

Muhammed Aasim Yusuf, Vinay Kumar Kapoor, Refaat Refaat Kamel, Ather Kazmi, Najam Uddin, Nehal Masood, and Abdulmajeed Al-Abdulkareem

: hepatocellular cancer, cancer of the gallbladder, extrahepatic cholangiocarcinoma, and intrahepatic cholangiocarcinoma. The incidence of hepatocellular cancer seems to be significantly higher in the Middle East and North Africa (MENA) region than in the West

Full access

Ali Bazarbachi and Andrew D. Zelenetz

NCCN Non-Hodgkin’s Lymphomas Panel, and Dr. Bazarbachi serves as chair of the NCCN-MENA Lymphomas Panel. Figure 1 Official United Nations MENA (Middle East and North Africa) region. Turkey was added for the NCCN-MENA project, and Pakistan, Sudan